By Associate Professor Suzanne Jean Hodgkinson

Conference Abstracts

Chen JC; Robinson C; Plain KM; He XY; Verma ND; Hodgkinson SJ; Hall BM, 2001, 'Role of cytokines in maintenance of transplantation tolerance by CD4+, CD25+ TR cells', in 19th Scientific Meeting The Transplantation society of Australia and New Zealand, 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, pp. 18 - 18, presented at 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, 04 April 2001 - 06 April 2001

Robinson C; Chen JC; He XY; Verma ND; Hodgkinson SJ; Hall BM, 2001, 'The role of CD25+, CD4+ and CD25-, CD4+ T cells in alloimmune responses', in 19th Scientific Meeting The Transplantation society of Australia and New Zealand, 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, pp. 2 - 2, presented at 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, 04 April 2001 - 06 April 2001

Hall BM; Chen JC; Robinson C; He XY; Verma ND; Hodgkinson SJ, 2001, 'Therapy with monoclonal antibody to CD25 blocks function of CD4+, CD25+ T regulatory cells that maintain transplantation tolerance', in 19th Scientific Meeting The Transplantation society of Australia and New Zealand, 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, pp. 3 - 3, presented at 19th Scientific Meeting The Transplantation society of Australia and New Zealand, Canberra, 04 April 2001 - 06 April 2001

Chen JC; Huoam C; Plain KM; He XY; Hodgkinson SJ; Hall BM, 2001, 'CD4+, CD25+ T cells as regulators of alloimmune responses', in Transplantation Proceedings, Elsevier Science Inc, pp. 163 - 164

Hall BM; Chen JC; Robinson C; He XY; Plain KM; Verma ND; Hodgkinson SJ, 2001, 'Conditioned Dendritic cells as a temporal bridge between T Helper and cytotoxic cells', in Transplantation Proceedings, Elsevier Science Inc, pp. 195 - 196

Patents

He XY; Hall BM; Hodgkinson SJ, 2000, Methods of inducing Immune Tolerance., Patent No.

Preprints

De Brouwer E; Becker T; Werthen-Brabants L; Dewulf P; Iliadis D; Dekeyser C; Laureys G; Van Wijmeersch B; Popescu V; Dhaene T; Deschrijver D; Waegeman W; De Baets B; Stock M; Horakova D; Patti F; Izquierdo G; Eichau S; Girard M; Prat A; Lugaresi A; Grammond P; Kalincik T; Alroughani R; Grand’Maison F; Skibina O; Terzi M; Lechner-Scott J; Gerlach O; Khoury SJ; Cartechini E; Van Pesch V; Sa MJ; Weinstock-Guttman B; Blanco Y; Ampapa R; Spitaleri D; Solaro C; Maimone D; Soysal A; Iuliano G; Gouider R; Castillo-Triviño T; Sanchez-Menoyo JL; Laureys G; van der Walt A; Oh J; Aguera-Morales E; Altintas A; Al-Asmi A; de Gans K; Fragoso Y; Csepany T; Hodgkinson S; Deri N; Al-Harbi T; Taylor B; Gray O; Lalive P; Rozsa C; McGuigan C; Kermode A; Perez sempere A; Mihaela S; Simo M; Hardy T; Decoo D; Hughes S; Grigoriadis N; Sas A; Vella N; Moreau Y; Peeters L, 2022, Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study, , http://dx.doi.org/10.1101/2022.09.08.22279617

Maltby VE; Lea RA; Monif M; Fabis-Pedrini MJ; Buzzard K; Kalincik T; Kermode AG; Taylor B; Hodgkinson S; McCombe P; Butzkueven H; Barnett M; Lechner-Scott J, 2020, Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study) (Preprint), , http://dx.doi.org/10.2196/preprints.24969

Kalincik T; Sharmin S; Malpas C; Spelman T; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Jokubaitis V; van der Walt A; Grand’Maison F; Sola P; Ferraro D; Shaygannejad V; Alroughani R; Hupperts R; Terzi M; Boz C; Lechner-Scott J; Pucci E; Van Pesch V; Granella F; Bergamaschi R; Spitaleri D; Slee M; Vucic S; Ampapa R; McCombe P; Ramo-Tello C; Prevost J; Olascoaga J; Cristiano E; Barnett M; Saladino ML; Sanchez-Menoyo JL; Hodgkinson S; Rozsa C; Hughes S; Moore F; Shaw C; Butler E; Skibina O; Gray O; Kermode A; Csepany T; Singhal B; Shuey N; Piroska I; Taylor B; Simo M; Sirbu C-A; Sas A; Butzkueven H, 2019, Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years, , http://dx.doi.org/10.1101/735662

Back to profile page